Health Condition 1: J399- Disease of upper respiratory tract, unspecified
Conditions
Interventions
Intervention1: 1) Group A Trail Drug (Nidigdhikadi Leha): The proposed Trail Drug in Avleha Form Nidigdhikladi Leha 180-200 mg/Kg/Day Into Two Divided Doses for 8 Weeks.
Route of Administration: Oral,
Sponsors
National Institute of Ayurveda Jaipur
Eligibility
Inclusion criteria
Inclusion criteria: 1) Children aged between 6 to 12 years of either sex. 2) Children with recurrent upper respiratory infections. 3) Children whose parents are willing to give consent for clinical trail.
Exclusion criteria
Exclusion criteria: 1) Children suffering from major systemic illness necessitating hospitalization. 2) Children with evidence of malignancy, genetic or congenital anomaly. 3) Children with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S. creatinine >1.2mg/dl) uncontrolled pulmonary dysfunction (asthmatic and COPD patients) 4) Chronic illness like TB, UTI and bleeding disorders etc. 5) H/o hypersensitivity to any of the trial drug or their ingredients. 6) Children who have completed participation in any other clinical trial during the past six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Morbidity ScoreTimepoint: 8 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease in episodes of Upper Respiratory Tract InfectionsTimepoint: 8 Weeks | — |
Countries
India
Contacts
Public ContactDr Nisha kumari Ojha
National Institute of Ayurveda
Outcome results
None listed